The Challenge Non-Typhoidal Salmonella (CHANTS) Consortium: Development of a non-typhoidal Salmonella controlled human infection model: Report from a consultation group workshop, 05 July 2022, London, UK [version 2; peer review: 2 approved]

The Challenge Non-Typhoidal Salmonella (CHANTS) Consortium: Development of a non-typhoidal Salmonella controlled human infection model: Report from a consultation group workshop, 05 July 2022, London, UK [version 2; peer review: 2 approved]

Invasive non-typhoidal Salmonella disease (iNTS) is a major cause of morbidity and mortality globally, particularly as a cause of bloodstream infection in children and immunocompromised adults in sub-Saharan Africa. Vaccines to prevent non-typhoidal Salmonella (NTS) would represent a valuable public...

Full description

Bibliographic Details
Main Authors: James E. Meiring, Emma Smith, Peter W.S. Hill, Malick M. Gibani, Megan E. Carey, Christopher Chiu, Melita Gordon, Graham Cooke, Thomas C. Darton, Jay Hinton, Christopher Smith, Robert K.M. Choy, Blanca Perez Sepulveda
Format: Article
Language:English
Published: Wellcome 2023-09-01
Series:Wellcome Open Research
Subjects:
Salmonella; Salmonella Typhimurium; Non-Typhoidal Salmonella; Human Challenge Model; Controlled Human Infection Model; Vaccines
eng
Online Access:https://wellcomeopenresearch.org/articles/8-111/v2

Internet

https://wellcomeopenresearch.org/articles/8-111/v2

Similar Items